Genmab A/S (GMAB.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec30

Genmab Expects Multiple Pivotal Trial Readouts in 2026

16:51

DNB Carnegie lowers Genmab's target price to 1985 Danish Krone

05:43

Dec29

Genmab A/S Halts Clinical Development of Acasunlimab

13:17

Dec23

Genmab A/S stock reaches new high

21:40

Genmab A/S Acquires Merus Shares Leading to Executive Changes

03:26

Dec22

Genmab A/S Acquires Additional Ordinary Shares in Merus NV

22:16

Schedules & Filings

Schedules

Filings

Feb17

Earning Release(EST)

FY2025 Annual Earning Release

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.022 B, Net Income 401 M, EPS 0.646

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 925 M, Net Income 336 M, EPS 0.542

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More